The role of diet and nutrition in cervical carcinogenesis: A review of recent evidence

International Journal of Cancer

Volumn 117, Issue 4, 2005, Pages 629-637

  García Closas, Reina ^a   Castellsagué, Xavier ^a   Bosch, Xavier ^a   González, Carlos A ^a  

^a CATALAN INSTITUTE OF ONCOLOGY   (Spain)

Author keywords

Cervical cancer; Epidemiology; Human papillomavirus; Nutrition; Review

Indexed keywords

ALPHA CAROTENE; ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; CRYPTOXANTHIN; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; LYCOPENE; PYRIDOXINE; RETINOL; ZEAXANTHIN;

BLOOD LEVEL; CANCER INVASION; CANCER RISK; CARCINOGENESIS; CLINICAL TRIAL; DIETARY INTAKE; FEMALE; FRUIT; HUMAN; META ANALYSIS; NUTRIENT; NUTRITIONAL STATUS; PRECANCER; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; REVIEW; SYSTEMATIC REVIEW; UTERINE CERVIX CANCER; VEGETABLE; WART VIRUS;

CAROTENOIDS; CELL TRANSFORMATION, NEOPLASTIC; CYSTEINE; DIET; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; METHIONINE; NUTRITION PHYSIOLOGY; UTERINE CERVICAL NEOPLASMS; VITAMINS;

EID: 27144516904     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.21193     Document Type: Review

References (56)

1. Parkin DM. Cancer burden in the year 2000. The global picture. Eur J Cancer 2001;37:S4-S66.
2. Schiffman M, Kjaer SK. Natural history of anogenital human papillomavirus infection and neoplasia. J Natl Cancer Inst 2003;31:14-9.
3. Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002;55:244-65.
4. Ho GY, Burk RD, Klein S, Kadish AS, Chang CJ, Palan P, Basu J, Tachezy R, Lewis R, Romney S. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 1995;87:1365-71.
5. Stuver S, Adami HO. Cervical cancer. In: Adami HO, Hunter D, Trichopoulous D, eds. Textbook of cancer epidemiology. New York: Oxford University Press, 2002. 340-58.
6. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998;338;423-8.
7. Castellsagué X, Muñoz N. Cofactors in human papillomavirus carcinogenesis-role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr 2003;31:20-8.
8. Potischman N, Brinton LA. Nutrition and cervical neoplasia. Cancer Causes Control 1996;7:113-26.
9. World Cancer Research Fund. Food, nutrition and the prevention of cancer. A global perspective. Washington, DC: American Institute for Cancer Research, 1997. 301-8.
10. Working Group on Diet and Cancer of the Committee of Medical Aspects of Food and Nutrition Policy. Department of Health. Nutritional aspects of the development of cancer. 48th Report on Health and Social Subjects. Norwich: The Stationery Office, 1998. 136-40.
11. Sedjo RL, Inserra P, Abrahamsen M, Harris RB, Roe DJ, Baldwin S, Giuliano AR. Human papillomavirus persistence and nutrients involved in the methylation pathway among a cohort of young women. Cancer Epidemiol Biomarkers Prev 2002;11:353-9.
12. Sedjo RL, Fowler BM, Schneider A, Henning SM, Hatch K, Giuliano AR. Folate, vitamin B12, and homocysteine status: findings of no relation between human papillomavirus persistence and cervical dysplasia. Nutrition 2003;19:497-502.
13. Wideroff L, Potischman N, Glass AG, Greer CE, Manos MM, Scott DR, Burk RD, Sherman ME, Wacholder S, Schiffman M. A nested case-control study of dietary factors and the risk of incident cytological abnormalities of the cervix. Nutr Cancer 1998;30:130-6.
14. Kanetsky PA, Gammon MD, Mandelblatt J, Zhang ZF, Ramsey E, Dnistrian A, Norkus EP, Wright TC Jr. Dietary intake and blood levels of lycopene: association with cervical dysplasia among non-hispanic, black women. Nutr Cancer 1998;31:31-40.
15. Goodman MT, McDuffie K, Hernandez B, Wilkens LR, Bertram CC, Killeen J, Le Marchand L, Selhub J, Murphy S, Donlon TA. Association of methylentetrahydrofolate reductase polymorphism C677T and dietary folate with the risk of cervical dysplasia. Cancer Epidemiol Biomarkers Prev 2001;10:1275-80.
16. Shannon J, Thomas DB, Ray RM, Kestin M, Koetsawang A, Koetsawang S, Chitnarong K, Kiviat N, Kuypers J. Dietary risk factors for invasive and in situ cervical carcinomas in Bangkok, Thailand. Cancer Causes Control 2002;13:691-9.
17. Kjellberg L, Hallmans G, Ahren AM, Johansson R, Bergman F, Wadell G, Angstrom T, Dillner J. Smoking, diet, pregnancy and oral contraceptive use as risk factors for cervical intra-epithelial neoplasia in relation to human papillomavirus infection. Br J Cancer 2000;82:1332-8.
18. Weinstein SJ, Ziegler RG, Frongillo EA Jr, Colman N, Sauberlich HE, Brinton LA, Hamman RF, Levine RS, Mallin K, Stolley PD, Bisogni CA. Low serum and red blood cell folate are moderately but non significantly associated with increased risk of invasive cervical cancer in U.S. women. J Nutr 2001;131:2040-8.
19. Kwasniewska A, Tukendorf A, Semczuk M. Folate deficiency and cervical intraepithelial neoplasia. Eur J Gynaecol Oncol 1997;18:526-30.
20. Alberg AJ, Selhub J, Shah KV, Viscidi RP, Comstock GW, Helzlsouer KJ. The risk of cervical cancer in relation to serum concentrations of folate, vitamin B12, and homocysteine. Cancer Epidemiol Biomarkers Prev 2000;9:761-4.
21. Goodman MT, McDuffie K, Hernandez B, Wilkens LR, Selhub J. Case-control study of plasma folate, homocysteine, vitamin B12, and cysteine as markers of cervical dysplasia. Cancer 2000;89:376-82.
22. Kwasniewska A, Tukendorf A, Gozdzicka-Jozefiak A, Semczuk-Sikora A, Korobowicz E. Content of folic acid and free homocysteine in blood serum of human papillomavirus-infected women with cervical dysplasia. Eur J Gynaecol Oncol 2002;23:311-6.
23. Yeo AS, Schiff ME, Montoya G, Masuk M, van Asselt-King L, Becker TM. Serum micronutrients and cervical dysplasia in Southwestern American Indian women. Nutr Cancer 2000;38:141-50.
24. Butterworth CE Jr, Hatch KD, Soong SJ, Cole P, Tamura T, Sauberlich HE, Borst M, Macaluso M, Baker V. Oral folic acid supplementation for cervical dysplasia: a clinical intervention trial. Am J Obstet Gynecol 1992;166:803-9.
25. Childers JM, Chu J, Voigt LF, Feigl P, Tamimi HK, Franklin EW, Alberts DS, Meyskens FL Jr. Chemoprevention of cervical cancer with folie acid: a phase III Southwest Oncology Group Intergroup study. Cancer Epidemiol Biomarkers Prev 1995;4:155-9.
26. Weinstein SJ, Ziegler RG, Selhub J, Fears TR, Strickler HD, Brinton LA, Hamman RF, Levine RS, Mallin K, Stolley PD. Elevated serum homocysteine levels and increased risk of invasive cancer in US women. Cancer Causes Control 2001;12:317-24.
27. Thomson SW, Heimburger DC, Cornwell PE, Turner ME, Sauberlich HE, Fox LM, Butterworth CE. Effect of total plasma homocysteine on cervical dysplasia risk. Nutr Cancer 2000;37:128-33.
28. Ziegler RG, Weinstein SJ, Fears TR. Nutritional and genetic inefficiencies in one-carbon metabolism and cervical cancer risk. J Nutr 2002;132:2345S-9S.
29. Giuliano AR, Papenfuss M, Nour M, Canfield LM, Schneider A, Hatch K. Antioxidant nutrients: associations with persistent human papillomavirus infection. Cancer Epidemiol Biomarkers Prev 1997;6:917-23.
30. Sedjo RL, Roe DJ, Abrahamsen M, Harris RB, Craft N, Baldwin S, Giuliano AR. Vitamin A, carotenoids, and the risk of persistent oncogenic human papillomavirus infection. Cancer Epidemiol Biomarkers Prev 2002;11:876-84.
31. Giuliano AR, Siegel EM, Roe DJ, Ferreira S, Baggio ML, Galan L, Duarte-Franco E, Villa LL, Rohan TE, Marshall JR, Franco EL. Dietary intake and risk of persistent Human Papillomavirus (HPV) infection: the Ludwig-McGill HPV natural history study. JID 2003;188:1508-16.
32. Palan PR, Chang CJ, Mikhail MS, Ho GY, Basu J, Romney SL. Plasma concentrations of micronutrients during a nine-month clinical trial of beta-carotene women with precursor cervical lesions. Nutr Cancer 1998;30:46-52.
33. Schiff MA, Patterson RE, Baumgartner RN, Masuk M, van Asselt-King L, Wheeler CM, Becker TM. Serum carotenoids and risk of cervical intraepithelial neoplasia in Southwestern American Indian women. Cancer Epidemiol Biomarkers Prev 2001;10:1219-22.
34. Ho GY, Palan PR, Basu J, Romney SL, Kadish AS, Mikhail M, Wassertheil-Smoller S, Runowicz C, Burk RD. Viral characteristics of Human Papillomavirus infection and antioxidant levels as risk factors for cervical dysplasia. Int J Cancer 1998;78:594-9.
35. Goodman MT, Kiviat N, McDuffie K. The association of plasma micronutrients with the risk of cervical dysplasia in Hawaii. Cancer Epidemiol Biomarkers Prev 1998;7:537-44.
36. Nagata C, Shimizu H, Yoshikawa H, Noda K, Nozawa S, Yajima A, Sekiya S, Sugimori H, Hirai Y, Kanazawa K, Sugase M, Kawana T. Serum carotenoids and vitamins and risk of cervical dysplasia from a case-control study in Japan. Br J Cancer 1999;81:1234-7.
37. Mackerras D, Irwig L, Simpson JM, Weisberg E, Cardona M, Webster F, Walton L, Ghersi D. Randomized double-blind trial of beta-carotene and vitamin C in women with minor cervical abnormalities. Br J Cancer 1999;79:1448-53.
38. Keefe KA, Schell MJ, Brewer C, McHale M, Brewster W, Chapman JA, Rose GS, McMeeken DS, Lagerberg W, Peng YM, Wilczynski SP, Anton-Culver H, et al. A randomized, double blind, phase III trial using oral beta-carotene supplementation for women with high-grade cervical intraepithelial neoplasia. Cancer Epidemiol Biomarkers Prev 2001;10:1029-35.
39. Fairley CK, Tabrizi SN, Chen S, Baghurst P, Young H, Quinn M, Medley G, McNeil JJ, Garland SM. A randomized clinical trial of beta carotene vs. placebo for the treatment of cervical HPV infection. Int J Gynecol Cancer 1996;6:225-30.
40. Romney SL, Ho GY, Palan PR, Basu J, Kadish AS, Klein S, Mikhail M, Hagan RJ, Chang CJ, Burk RD. Effects of b-carotene and other factors on outcome of cervical dysplasia and human papillomavirus infection. Gynecol Oncol 1997;65:483-92.
41. de Vet HC, Knipschild PG, Willebrand D, Schouten HJ, Sturmans F. The effect of beta-carotene on the regression and progression of cervical dysplasia: a clinical experiment. J Clin Epidemiol 1997;44:273-83.
42. Liu T, Soong SJ, Alvarez RD, Butterworth C. A longitudinal analysis of human papillomavirus 16 infection, nutritional status, and cervical dysplasia progression. Cancer Epidemiol Biomarkers Prev 1995;4:373-80.
43. Lehtinen M, Luostarinen T, Youngman LD, Anttila T, Dillner J, Hakulinen T, Koskela P, Lenner P, Hallmans G. Low levels of serum vitamins A and E in blood and subsequent risk for cervical cancer: interaction with HPV seropositivity. Nutr Cancer 1999;34:229-34.
44. Alvarez RD, Conner MG, Weiss H, Klug PM, Niwas S, Manne U, Bacus J, Kagan V, Sexton KC, Grubbs CJ, Eltoum IE, Grizzle WE. The efficacy of 9-Cis-Retinoic Acid (Aliretinoin) as a chemopreventive agent for cervical dysplasia: results of a randomized double-blind clinical trial. Cancer Epidemiol Biomarkers Prev 2003;12:114-9.
45. Meyskens FL Jr, Surwit E, Moon TE, Childers JM, Davis JR, Dorr RT, Johnson CS, Alberts DS. Enhancement of regression of cervical intraepithelial neoplasia 11 (Moderate dysplasia) with topically applied All-trans-retinoic acid: a randomized trial. J Natl Cancer Inst 1994;86:539-43.
46. Follen M, Atkinson EN, Schottenfeld D, Malpica A, West L, Lippman S, Zou C, Hittelman WN, Lotan R, Hong WK. A randomized clinical trial of 4-hydroxyphenylretinamide for high-grade squamous intraepithelial lesions of the cervix. Clin Cancer Res 2001;7:3356-65.
47. Castle PE, Giuliano AR. Chapter 4: genital tract infections, cervical inflammation, and antioxidant nutrients-assessing their roles as Human Papillomavirus cofactors. J Natl Cancer Inst 2003;31:29-34.
48. Follen M, Meyskens FL, Atkinson EN, Schottenfeld D. Why most randomized phase II cervical cancer chemoprevention trials are uninformative: lessons for the future. J Natl Cancer Inst 2001;93:1293-6.
49. Giuliano AR, Gapstur S. Can cervical dysplasia and cancer be prevented with nutrients? Nutr Rev 1998;56:9-16.
50. Potischman N, Hoover RN, Brinton LA, Swanson CA, Herrero R, Tenorio F, de Britton RC, Gaitan E, Reeves WC. The relations between cervical cancer and serological makers of nutritional status. Nutr Cancer 1994;21:193-201.
51. Willett W. Nutritional epidemiology, 2nd ed. New York: Oxford University Press, 1998. 174-243.
52. Frei B. Natural antioxidants in human health and disease. San Diego: Academic Press, 1994.
53. Eiserich JP, van der Vliet A, Handelman GJ, Halliwell B, Cross CE. Dietary antioxidants and cigarette smoke-induced biomolecular damage: a complex interaction. Am J Clin Nutr 1995;62:1490S-500S.
54. Cheng Y, Li HL, Wang HF, Sun HF, Liu YF, Peng SX, Liu KX, Guo ZY. Inhibition of nicotine-DNA adduct formation in mice by six dietary constituents. Food Chem Toxicol 2003;41:1045-50.
55. Palli D, Masala G, Vineis P, Garte S, Saieva C, Krogh V, Panico S, Tumino R, Munnia A, Riboli E, Peluso M. Biomarkers of dietary intake of micronutrients modulate DNA adduct levels in healthy adults. Carcinogenesis 2003;24:739-46.
56. Alberg A. The influence of cigarette smoking on circulating concentrations of antioxidant micronutrients. Toxicology 2002;180:121-37.